Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone ACetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00887198
What this trial is testing

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 1,088
Testing effectiveness (Phase 2)Study completedNCT02962284
What this trial is testing

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

Who this might be right for
Metastatic Prostate Cancer
Sun Pharmaceutical Industries Limited 20
Not applicableUnknownNCT02787837
What this trial is testing

PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.

Who this might be right for
Advanced Prostate CancerAbiraterone ACetate
Centro Nacional de Investigaciones Oncologicas CARLOS III 220
Large-scale testing (Phase 3)Looking for participantsNCT06136650
What this trial is testing

Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC 1,314
Large-scale testing (Phase 3)Study completedNCT00638690
What this trial is testing

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Prostatic Neoplasms
Cougar Biotechnology, Inc. 1,195
Testing effectiveness (Phase 2)Study completedNCT02036060
What this trial is testing

Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastatic Castration Resistant Prostate Cancer.

Who this might be right for
Metastatic Prostate Cancer
Spanish Oncology Genito-Urinary Group 119
Large-scale testing (Phase 3)Study completedNCT02987543
What this trial is testing

Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 387
Testing effectiveness (Phase 2)Ended earlyNCT01845792
What this trial is testing

Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Colorado, Denver 7
Testing effectiveness (Phase 2)Study completedNCT01717053
What this trial is testing

Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 37
Testing effectiveness (Phase 2)Study completedNCT00473746
What this trial is testing

Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 66
Testing effectiveness (Phase 2)WithdrawnNCT06527690
What this trial is testing

Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerCastrate Resistant Prostate CancerHomologous Recombination Deficiency
Latin American Cooperative Oncology Group
Not applicableWithdrawnNCT01692483
What this trial is testing

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Pharmaceutica
Testing effectiveness (Phase 2)WithdrawnNCT06392841
What this trial is testing

Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Deleterious HRR Gene MutationBRCA1 Gene Mutation+7 more
Qian Qin
Not applicableStudy completedNCT02813408
What this trial is testing

Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants

Who this might be right for
Prostatic Neoplasms
Janssen Pharmaceutica N.V., Belgium 226
Large-scale testing (Phase 3)Study completedNCT02043678
What this trial is testing

Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms

Who this might be right for
Prostatic Neoplasms
Bayer 806
Testing effectiveness (Phase 2)Ended earlyNCT05405439
What this trial is testing

To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 39
Large-scale testing (Phase 3)Study completedNCT01715285
What this trial is testing

Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 1,209
Early research (Phase 1)Study completedNCT04666129
What this trial is testing

Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Sensitive Prostate CancerNon-Metastatic Castration-Resistant Prostate Cancer
Sumitomo Pharma America, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT01314118
What this trial is testing

IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

Who this might be right for
Prostate CancerProstatic Neoplasm
Janssen Biotech, Inc. 131
Early research (Phase 1)Study completedNCT01873001
What this trial is testing

Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants

Who this might be right for
Healthy Volunteers
Janssen Research & Development, LLC 16
Next Page